RT Journal Article
SR Electronic
T1 714 Phase 1a trial of PLN-101095, an integrin αvβ8 and αvβ1 inhibitor, as monotherapy and in combination with pembrolizumab, in treatment-resistant patients with advanced or metastatic solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A809
OP A809
DO 10.1136/jitc-2023-SITC2023.0714
VO 11
IS Suppl 1
A1 Daud, Adil
A1 Barnes, Chris N
A1 Owen, Susan
A1 Turner, Scott M
A1 Sznol, Mario
A1 Lefebvre, Eric A
A1 Achneck, Hardean E
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A809.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.